• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN
October 5, 2016 10:44 AM EDT
News Briefing

Biotech bil­lion­aire backs a food al­ler­gy/nu­tri­tion start­up; Ed­i­tas re­cruits a CMO

ENDPOINTS

Swiss biotech bil­lion­aire Ernesto Bertarel­li is putting some of his cash in­to a new Sil­i­con Val­ley start­up that will look to help pre­vent food …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

more like this

  • Prime Med­i­cine CSO de­parts, re­veals new fund­ing; FDA lifts par­tial hold on Kezar drug July 16, 2025
  • Ot­su­ka buys im­munol­o­gy drugs; JCR, Acu­men team up on Alzheimer’s pro­gram July 15, 2025
  • Boehringer, LEO ink deal for IL-36 drug; Bay­er’s Keren­dia gets an­oth­er in­di­ca­tion July 14, 2025
TRENDING NOW

Sarep­ta adds black box warn­ing to its Duchenne treat­ment, cuts 500 work­ers

RFK reshuf­fles top HHS lead­er­ship, re­plac­ing his chief of staff and an­oth­er top aide

PureTech CEO leaves just one week af­ter long­time chair steps down

Wear­able mak­er Whoop to fight FDA over blood pres­sure track­er

FDA drugs cen­ter sees sharp rise in staff de­par­tures since Jan­u­ary

As­traZeneca says amy­loi­do­sis drug fails Phase 3 tri­als, but claims po­ten­tial in undis­closed sub­group

Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times